Center of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Children's Medical Center Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Science. 2024 Nov 15;386(6723):eadh9215. doi: 10.1126/science.adh9215.
Metabolic requirements vary during development, and our understanding of how metabolic activity influences cell specialization is incomplete. Here, we describe a switch from glutamine catabolism to synthesis required for erythroid cell maturation. Glutamine synthetase (GS), one of the oldest functioning genes in evolution, is activated during erythroid maturation to detoxify ammonium generated from heme biosynthesis, which is up-regulated to support hemoglobin production. Loss of GS in mouse erythroid precursors caused ammonium accumulation and oxidative stress, impairing erythroid maturation and recovery from anemia. In β-thalassemia, GS activity is inhibited by protein oxidation, leading to glutamate and ammonium accumulation, whereas enhancing GS activity alleviates the metabolic and pathological defects. Our findings identify an evolutionarily conserved metabolic adaptation that could potentially be leveraged to treat common red blood cell disorders.
代谢需求在发育过程中会发生变化,而我们对代谢活动如何影响细胞特化的理解还不完全。在这里,我们描述了红细胞成熟过程中从谷氨酰胺分解代谢到合成代谢的转变。谷氨酰胺合成酶(GS)是进化过程中最古老的功能基因之一,在红细胞成熟过程中被激活,以解毒血红素生物合成产生的铵,血红素生物合成被上调以支持血红蛋白的产生。在小鼠红细胞前体中敲除 GS 会导致铵积累和氧化应激,从而损害红细胞成熟和贫血恢复。在β-地中海贫血中,GS 活性被蛋白氧化抑制,导致谷氨酸和铵积累,而增强 GS 活性则可以减轻代谢和病理缺陷。我们的研究结果确定了一种进化上保守的代谢适应性,这可能为治疗常见的红细胞疾病提供新的思路。